| Literature DB >> 35548382 |
Wei-Shi Hong1, Ya-Xin Zhang1, Qun Lin1, Yu Sun2.
Abstract
Purpose: To investigate the risk factors of increased hidden blood loss (HBL) after total hip arthroplasty (THA) for femoral neck fracture in elderly women and establish the nomogram prediction model for the guidance to reduce HBL in clinic. Patients andEntities:
Keywords: femoral neck fracture; hidden blood loss; nomogram prediction model; risk factors; total hip arthroplasty
Mesh:
Substances:
Year: 2022 PMID: 35548382 PMCID: PMC9081002 DOI: 10.2147/CIA.S363682
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 3.829
Perioperative Parameters of Patients
| Parameter | Mean ± SD or N (%) |
|---|---|
| Hematocrit level loss (%) | 7.0±3.6 |
| Hemoglobin loss (g/L) | 15.1±10.4 |
| Hemoglobin <100 g/L preoperatively (n) | 26 (12.6%) |
| Hemoglobin <100 g/L postoperatively (n) | 76 (36.9%) |
| Calculated total blood loss (mL) | 799±411 |
| Visible blood loss (mL) | 173±82 |
| Hidden blood loss (mL) | 626±400 |
| Percentage of hidden blood loss in total (%) | 72.8±18.4 |
Correlation Analysis Results of Perioperative Hidden Blood Loss Parameters and Independent Sample t-Test
| Index | Groups | N | HBL (mL) | T | P |
|---|---|---|---|---|---|
| Hypertension* | With | 100 | 743±432 | 4.208 | 0.000 |
| Without | 106 | 516±332 | |||
| ASA | ≥3 | 85 | 636±412 | 0.292 | 0.771 |
| <3 | 121 | 619±392 | |||
| Osteoporosis* | With | 89 | 787±467 | 5.042 | 0.000 |
| Without | 117 | 504±286 | |||
| Preoperative | Normal | 109 | 464±274 | 6.649 | 0.000 |
| Blood calcium (mmol/L)* | Low | 97 | 808±439 |
Note: Data are expressed as mean ±SD, *P<0.05.
Abbreviation: ASA, American Society of Anesthesiologists.
Perioperative Hidden Blood Loss Parameters and Pearson Correlation Analysis Results
| Parameter | Mean ± SD or N (%) | Pearson Value | P value |
|---|---|---|---|
| Age (year)* | 73.64±6.79 | −0.171 | 0.014 |
| BMI (kg/m2) | 22.73±3.58 | 0.043 | 0.540 |
| The operative time (min)* | 66.99±25.18 | 0.252 | 0.000 |
| Preoperative HGB (g/L)* | 118.88±14.68 | 0.147 | 0.036 |
| Preoperative RBC (1012/L) | 3.92±0.49 | 0.120 | 0.087 |
| Preoperative HCT (%)* | 35.95±4.11 | 0.151 | 0.030 |
| Preoperative PLT (109/L) | 180.53±70.54 | 0.049 | 0.482 |
| Preoperative PT (s) | 13.43±1.13 | −0.042 | 0.547 |
| Preoperative APTT (s)* | 38.14±7.49 | −0.149 | 0.033 |
| Preoperative PT-INR | 1.78±5.53 | 0.060 | 0.392 |
| Preoperative TT (s) | 18.02±2.53 | −0.025 | 0.723 |
| Preoperative FIB (g/L) | 3.88±1.35 | −0.064 | 0.363 |
| Preoperative DD polymer (ug/mL) | 5.49±5.55 | −0.029 | 0.680 |
| Preoperative CRP (mg/L)* | 27.10±26.80 | −0.157 | 0.024 |
| Preoperative ESR (mm/h) | 26.53±18.41 | −0.025 | 0.727 |
| Intraoperative blood loss (mL) | 172.82±81.83 | 0.043 | 0.539 |
| Estimated blood volume (mL) | 3079.86±581.68 | −0.038 | 0.588 |
Note: Data are expressed as mean ±SD, *P<0.05.
Abbreviations: BMI, body mass index; HGB, hemoglobin; RBC, red blood cell; HCT, hematocrit; PLT, platelet; PT, prothrombin time; APTT, activated partial thrombin time; INR, international normalized ratio; TT, thrombin time; FIB, fibrinogen; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate.
Multiple Linear Regression Analysis of HBL Risk Factors After THA
| Coefficient B | SE | T Value | P value | |
|---|---|---|---|---|
| Constant | 600.182 | 394.391 | 1.522 | 0.130 |
| Age (year)* | −9.271 | 3.587 | −2.585 | 0.010 |
| Operative time (min)* | 2.653 | 0.914 | 2.903 | 0.004 |
| Preoperative blood calcium (mmol/L)* | 232.492 | 48.120 | 4.832 | 0.000 |
| Hypertension* | 150.352 | 47.920 | 3.138 | 0.002 |
| Osteoporosis* | 276.072 | 47.668 | 5.791 | 0.000 |
| Preoperative HGB (g/L) | 1.675 | 5.812 | 0.288 | 0.773 |
| Preoperative HCT (%) | 2.897 | 20.775 | 0.139 | 0.889 |
| Preoperative CRP (mg/L) | −1.031 | 0.866 | −1.190 | 0.236 |
| Preoperative APTT (s) | −1.218 | 3.119 | −0.390 | 0.697 |
Notes: *P<0.05. Multiple linear regression analysis adjusted for all variables in the table adjusted R2 =0.369.
Abbreviations: HGB, hemoglobin; HCT, hematocrit; APTT, activated partial thrombin time; CRP, C-reactive protein.
Figure 1Nomogram of blood transfusions after THA in elderly women.
Figure 2ROC curve of blood transfusion in elderly female patients after THA.
Figure 3Calibration curves for the prediction of blood transfusions after THA in elderly female patients.